Stochastic dynamics of human papillomavirus delineates cervical cancer progression
From MaRDI portal
Publication:6181117
DOI10.1007/s00285-023-02018-zMaRDI QIDQ6181117
Jin-qiao Duan, Tuan Anh Phan, Jianjun Paul Tian, Farhana Sarower
Publication date: 2 January 2024
Published in: Journal of Mathematical Biology (Search for Journal in Brave)
cervical cancerergodic invariant probability measurestochastic dynamical bifurcationchronic infection state
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- The dynamics of HPV infection and cervical cancer cells
- A male-female mathematical model of human papillomavirus (HPV) in African American population
- The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study
- Stochastic stability of differential equations. With contributions by G. N. Milstein and M. B. Nevelson
- Global stability of equilibria in a two-sex HPV vaccination model
- Statistical properties of the generalized inverse Gaussian distribution
- Coexistence and extinction for stochastic Kolmogorov systems
- Basic stochastic model for tumor virotherapy
- Deterministic and stochastic modeling for PDGF-driven gliomas reveals a classification of gliomas
- Hopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. II
- Hypoelliptic second order differential equations
- Conditions for permanence and ergodicity of certain stochastic predator–prey models
- Protection Zones for Survival of Species in Random Environment
- Stability of Markovian processes II: continuous-time processes and sampled chains
- Stability of Markovian processes III: Foster–Lyapunov criteria for continuous-time processes
- The Malliavin Calculus and Related Topics
- Dynamics of cholera epidemic models in fluctuating environments
- Ergodic Properties of Markov Processes
This page was built for publication: Stochastic dynamics of human papillomavirus delineates cervical cancer progression